CN Stock MarketDetailed Quotes

600422 KPC Pharmaceuticals, Inc.

Watchlist
  • 15.84
  • +1.16+7.90%
Market Closed Sep 30 15:00 CST
11.99BMarket Cap26.62P/E (TTM)

KPC Pharmaceuticals, Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

KPC Pharmaceuticals, Inc. Q2 2024 Earnings Date

Currency：CNYAug 23, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
--
1.70B
--
-8.54%
Net Income
--
112.73M
--
+17.05%
Analyst Rating
Strong Buy

Oct 1, 2024

KPC Pharmaceuticals, Inc. Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 8 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 9.779B--
--2024/FY-- / 8.491B--
Mar 22, 20242023/FY7.703B / 8.380B--
Mar 23, 20232022/FY8.282B / 8.537B--
Mar 19, 20222021/FY8.254B / 9.065B--
DatePeriodRevenue/EstimateEarnings Call
--2025/FY-- / 9.779B--
--2024/FY-- / 8.491B--
Mar 22, 20242023/FY7.703B / 8.380B--
Mar 23, 20232022/FY8.282B / 8.537B--
Mar 19, 20222021/FY8.254B / 9.065B--

Unlock Free Earnings Estimates

KPC Pharmaceuticals, Inc. Earnings Reports

  • kpc pharmaceuticals, inc. Semi-Annual Report for 2024

    Aug 22 12:00 ET

  • Summary of kpc pharmaceuticals, inc.'s 2024 interim report

    Aug 22 12:00 ET

  • KPC Group Report for the First Quarter of 2024

    Apr 19 12:00 ET

  • Summary of KPC's 2023 Annual Report

    Mar 21 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 1, 2024

    Strong Buy

    • Strong Buy

      75.00%

    • Buy

      25.00%

    • Hold

      0.00%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg

    No Data